Ramesh Keerthi Gadam M.B.B.S

• Knowledgeable radiation oncologist with robust background in brachytherapy, procedural skills at a high volume brachytherapy center.

• Gained ample proton therapy experience working in a N.C.I designated Comprehensive Cancer proton therapy center during medical residency.

• Demonstrated ability to manage patient care and treatment plans while collaborating with multidisciplinary teams.

• Skilled in patient communication and patient reported outcomes directed medical care.

• 2024 ABR Radiobiology Written Boards, Passed
• 2013 ABIM (American Board of Internal Medicine) certification
• 2020 ABIM (American Board of Internal Medicine) recertified.
• 2009 USMLE Step 3, Passed
• 2009 USMLE Step 2, Passed
• 2008 USMLE Step 1, Passed

• 2012 Osteoporosis Annual Academy Scholarship, International Society of Clinical Densitometry
• 2012 National ACP associates research abstract competition Winner, National American College of Physicians
• 2012 Nevada State ACP associate research competition, second place, Nevada State American College of Physicians
• 2012 Nevada State ACP associate research competition Winner, first place, American College Of Physicians, Nevada
• 2011 INBRE (IDea Network of Biomedical Research Excellence) grant winner, an NIH Grant given to UNSOM

• Frax prediction without BMD for assessment of osteoporotic fracture risk Ramesh Keerthi Gadam 1, Karen Schlauch2, Kenneth E Izuora2. This research was funded by INBRE (IDea Network of Biomedical Research Excellence) grant winner, an NIH Grant given to UNSOM, University of Nevada School of Medicine and resulted in a publication in Endocrine Practice 2013.
• Sarcopenia Predicts Poor Tolerance to Chemotherapy During Definitive Treatment of Primary Anal Squamous Cell Carcinoma R. Gadam1, C. E. Lominska2 and A. Hoover3 Abstract presentation at ASTRO 2023, and has been published in Red Journal 2023
• Muscle mass variation before ADT and after ADT in prostate cancer patients being treated with radiation therapy - Abstract presentation at ASTRO 2024, published in Red Journal 2024 R. Gadam 1, S. Gibson2, X. Shen3
• A Novel Volume Staged Stereotactic Radio Surgery Approach for Large Volume Arteriovenous Malformation and Clinical Outcomes-Being revised R.Gadam 1, F.Wang 2 Abstract presentation at ASTRO 2025, to be published in Red Journal 2025
• In Prostate Cancer Patients Stereotactic Body Radiation Therapy Every Day Regimen Has Similar or Mildly Improved Acute Patient Reported Outcomes Compared with Stereotactic Body Radiation Therapy Every Other Day Regimen R.Gadam 1, J.E. Einck2 Abstract presentation at ASTRO 2025, to be published in Red Journal 2025
• Short Duration Androgen Deprivation Therapy in Prostate Cancer Patients being Treated with Radiation Therapy Leads to Significant decline in Skeletal Muscle Mass and Worse Acute Patient Reported Outcomes R. Gadam 1, X. Shen2 Manuscript in progress
• Linac-Based Fractionated Stereotactic Radiosurgery (fSRS) for Cervical Spine Arteriovenous Malformation (AVM): A Case Report D.Soultan, J.Peterson , D.Stevenson , K.Gadam , F.Wang, R.Rotondo In review for publication.

09/1/25-10/31/25 (2 Months) American Brachytherapy Society 300 in 10, Brachytherapy fellowship at MD. Anderson Cancer Center.

• 2025 Onsite randomized clinical trial building workshop in April 2025 at MD Anderson Cancer Center
• 2024 Designed randomized IIT clinical trial prostate cancer with faculty University of Kansas
• 2023 KU SHP pilot grant (University of Kansas institutional grant) co-investigator
• 2012 INBRE (IDea Network of Biomedical Research Excellence) grant, an NIH Grant given to UNSOM, University of Nevada School of Medicine and resulted in a publication in Endocrine Practice 2013.

• Research conducted at University of Kansas Medical Center 08/22-present.
• "Sarcopenia Predicts Poor Tolerance to Chemotherapy During Definitive Treatment of Primary Anal Squamous Cell Carcinoma" Role: PI This was a retrospective study which assessed the clinical outcomes of Anal cancer patients who had low skeletal muscle mass or sarcopenia Abstract presentation at ASTRO 2023 and has been published in Red Journal 2023. Manuscript is in progress.
• “Short Duration Androgen Deprivation Therapy in Prostate Cancer Patients being Treated with Radiation Therapy Leads to Significant decline in Skeletal Muscle Mass and Worse Acute Patient Reported Outcomes” Role:PI This was a retrospective study which assessed the clinical outcomes and patient reported outcomes of prostate cancer patients who developed low skeletal muscle mass after a short duration of androgen deprivation therapy. Abstract presentation at ASTRO 2024 and published in Red Journal 2024. Manuscript is in progress.
• “In Prostate Cancer Patients Stereotactic Body Radiation Therapy Every Day Regimen Has Similar Or Mildly Improved Acute Patient Reported Outcomes Compared with Stereotactic Body Radiation Therapy Every Other Day Regimen” Role: PI Abstract presentation at ASTRO 2025. Manuscript is in progress. This was a retrospective study comparing the patient reported outcomes of prostate cancer patients being treated with Stereotactic Body Radiation Therapy every day compared with patients being treated with Stereotactic Body Radiation Therapy every other day as standard of care management.
• A Novel Volume Staged Stereotactic Radio Surgery Approach For Large Volume Arteriovenous Malformation and Clinical Outcomes Role:PI Abstract presentation at ASTRO 2025. Manuscript is in progress. This is a report of clinical outcomes for large volume aterio venous malformations treated with a novel volume staged stereotactic radiosurgery approach at The University of Kansas Medical Center from 2009-2024.
• Ongoing Research at University of Kansas School of Medicine “Examining how nutritional deficiency and inflammation are associated with head and neck cancer patient sarcopenia” Research dates 09/23-present Role: Co-Investigator KU pilot grant was awarded for this research.
• Designed randomized clinical trial for prostate cancer with the GU faculty at the University of Kansas. Stereotactic Body Radiation Therapy Every Day Regimen Compared with Stereotactic Body Radiation Therapy Every Other Day Regimen in Prostate Cancer Patients Receiving Stereotactic Body Radiation Therapy as Standard of Care
• Research conducted in University of Nevada School of Medicine 1/2012-4/2012 This research was funded by INBRE (IDea Network of Biomedical Research Excellence) grant, an NIH Grant given to UNSOM, University of Nevada School of Medicine and resulted in a publication in Endocrine Practice 2013. Role: PI This research was prospective clinical research and indicated that body weight, height and biological risk factors can predict osteoporotic fracture risk without BMD using an online FRAX tool. Gadam RK1, Schlauch K, Izuora KE. Frax prediction without BMD for assessment of osteoporotic fracture risk. Endocr Pract. 2013 Sep-Oct;19(5):780-4. PubMed Central PMCID: PMC4016963.
• Oral Presentation at Annual ACP internal medicine 2012 Role: PI Research conducted at University of Nevada School of Medicine Gadam.R1, Parizhar.F, Greenberg. A. “Can it wait until the morning?”- A retrospective study on the utility of gram stain culture reporting during after hours, was presented on the podium at National ACP (American College of Physicians) 2012, New Orleans, LA. Has been published in the ACP Annual Meeting Syllabus 2012.
• Research Conducted at University of Nevada School of Medicine from 01/12-03/12 Role: PI Gadam.R1, Smith.S, Leuthner.K, Greenberg.A. “To Treat or Not To Treat? Can Pro-calcitonin Differentiate Between Bacterial Colonization and Bacterial Infection?” – A prospective study on the clinical importance of pro-calcitonin to differentiate between bacterial colonization and bacterial infection in patients with chronically placed foley and tracheostomy. Presented at AACE (American Association of Clinical Endocrinologists) annual meeting 2013.Abstract published in AACE Annual Meeting Syllabus 2013.

Oral Presentations

• 2012 Annual ACP internal medicine “Can it wait until the morning?”- A retrospective study on the utility of gram stain culture reporting during after hours, was presented on the podium at National ACP (American College of Physicians) 2012, New Orleans, LA. Has been published in the ACP Annual Meeting Syllabus 2012.

Poster Presentations

• 2023 ASTRO Sarcopenia Predicts Poor Tolerance to Chemotherapy During Definitive Treatment of Primary Anal Squamous Cell Carcinoma
• 2024 ASTRO Muscle mass variation before ADT and after ADT in prostate cancer patients being treated with radiation therapy.
• 2025 ASTRO A Novel Volume Staged Stereotactic Radio Surgery Approach For Large Volume Arteriovenous Malformation and Clinical Outcomes
• 2025 ASTRO In Prostate Cancer Patients Stereotactic Body Radiation Therapy Every Day Regimen Has Similar or Mildly Improved Acute Patient Reported Outcomes Compared with Stereotactic Body Radiation Therapy Every Other Day Regimen